Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| JPMorgan Chase | 2.73% | $3.66M | $832.79B | 16.58% | 72 Outperform | |
| Enterprise Products Partners | 2.67% | $3.58M | $78.12B | 7.74% | 73 Outperform | |
| ASML Holding | 2.62% | $3.51M | $559.08B | 97.90% | 81 Outperform | |
| Morgan Stanley | 2.51% | $3.36M | $280.66B | 29.80% | 76 Outperform | |
| Novartis | 2.49% | $3.34M | $312.45B | 52.75% | 80 Outperform | |
| Exxon Mobil | 2.46% | $3.29M | $635.44B | 34.79% | 74 Outperform | |
| Merck & Company | 2.38% | $3.19M | $301.96B | 38.98% | 80 Outperform | |
| KLA | 2.36% | $3.16M | $194.03B | 89.02% | 77 Outperform | |
| Nexstar Media Group | 2.36% | $3.16M | $7.22B | 50.96% | 69 Neutral | |
| Broadcom | 2.28% | $3.05M | $1.58T | 52.74% | 76 Outperform |